- Home
- SAGE vs NOA Comparison
SAGE vs NOA Comparison
Compare SAGE & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- NOA
- Stock Information
- Founded
- SAGE 2010
- NOA 1953
- Country
- SAGE United States
- NOA Canada
- Employees
- SAGE N/A
- NOA N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- NOA Meat/Poultry/Fish
- Sector
- SAGE Health Care
- NOA Consumer Staples
- Exchange
- SAGE Nasdaq
- NOA Nasdaq
- Market Cap
- SAGE 415.0M
- NOA 399.1M
- IPO Year
- SAGE 2014
- NOA 2006
- Fundamental
- Price
- SAGE $6.71
- NOA $15.94
- Analyst Decision
- SAGE Hold
- NOA
- Analyst Count
- SAGE 19
- NOA 0
- Target Price
- SAGE $9.88
- NOA N/A
- AVG Volume (30 Days)
- SAGE 934.8K
- NOA 86.5K
- Earning Date
- SAGE 04-29-2025
- NOA 05-14-2025
- Dividend Yield
- SAGE N/A
- NOA 1.99%
- EPS Growth
- SAGE N/A
- NOA N/A
- EPS
- SAGE N/A
- NOA 1.05
- Revenue
- SAGE $47,404,000.00
- NOA $810,226,988.00
- Revenue This Year
- SAGE $100.64
- NOA $11.51
- Revenue Next Year
- SAGE $70.19
- NOA $4.38
- P/E Ratio
- SAGE N/A
- NOA $15.38
- Revenue Growth
- SAGE N/A
- NOA 20.85
- 52 Week Low
- SAGE $4.62
- NOA $13.19
- 52 Week High
- SAGE $14.56
- NOA $22.08
- Technical
- Relative Strength Index (RSI)
- SAGE 35.06
- NOA 55.52
- Support Level
- SAGE $7.23
- NOA $15.29
- Resistance Level
- SAGE $7.63
- NOA $15.82
- Average True Range (ATR)
- SAGE 0.29
- NOA 0.40
- MACD
- SAGE -0.09
- NOA 0.15
- Stochastic Oscillator
- SAGE 0.38
- NOA 90.84
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About NOA North American Construction Group Ltd. (no par)
North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.